日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.

用于超强效、持久抗病毒治疗的自适应多表位靶向和亲和力增强纳米抗体平台

Xiang Yufei, Xu Jialu, McGovern Briana L, Ranzenigo Anna, Huang Wei, Sang Zhe, Shen Juan, Diaz-Tapia Randy, Pham Ngoc Dung, Teunissen Abraham J P, Rodriguez M Luis, Benjamin Jared, Taylor Derek J, van Leent Mandy M T, White Kris M, García-Sastre Adolfo, Zhang Peijun, Shi Yi

Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals

SARS-CoV-2 N7-甲基转移酶与DOT1L和PRMT7抑制剂的结构为新型抗病毒药物的研发提供了平台

Kottur, Jithesh; White, Kris M; Rodriguez, M Luis; Rechkoblit, Olga; Quintana-Feliciano, Richard; Nayar, Ahana; García-Sastre, Adolfo; Aggarwal, Aneel K